CompletedNot Applicable

Zika Virus Infection's Pregnancy Consequences in French Department of America

French Guiana, Guadeloupe, Martinique26,980 participantsStarted 2016-04

Plain-language summary

The Zika (ZIKV) epidemic has spread into the three French Overseas Departments in the Caribbean (DFAs). It is therefore urgent to set up tools to collect clinical and paraclinical data for the evaluation of potential complications due to having ZIKV infection during pregnancy. This study is meant to collect, within usual care practices, clinical and paraclinical information which will allow the precise description of the consequences of ZIKV infection occurring during pregnancy.

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

M1: Inclusion Criteria: * On-going pregnancy regardless the presumed date of birth * Clinical signs suggestive of ZIKV infection * Whatever the RT-PCR analysis Exclusion Criteria: * Minor * No consent M2: Inclusion Criteria: * Head circumference \< 5th percentile * Other brain morphological abnormality * Hydramnios * Intrauterine growth restriction (IUGR) Exclusion Criteria: * Minor * No consent M3: Inclusion Criteria: * Pregnant woman during epidemic period of ZIKV Exclusion Criteria: * Minor * Opposition M4: Inclusion Criteria: * Delivery during epidemic period of ZIKV Exclusion Criteria: * Minor * No consent M5: Inclusion Criteria: * Spontaneous abortion or fetal death in utero during epidemic period of ZIKV Exclusion Criteria: * Minor * No consent

What they're measuring

Incidence of ZIKV infection during pregnancy

Timeframe: 12 months

Trial details

NCT IDNCT02916732

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2019-02